4 completed, 2 unknown, 1 terminated. 7 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Unknown 2, Terminated 1 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow ciclesonide: new trials by email Literature Review of ciclesonide trials Research Report on ciclesonide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V Niclosamide, Placebo, Ciclesonide - Covid19 | Phase 2 / Phase 3 | Completed | Cambridge University Hospitals NHS Foundation Trust | 2240 | 2021-02-19 | 2025-06-20 |
| Inhaled Ciclesonide for Outpatients With COVID19 Normal Saline intranasal and placebo inhaler, Ciclesonide, Ciclesonide nasal - COVID 19 | Phase 2 / Phase 3 | Terminated | McGill University Health Centre/Research Institute of the McGill University Health Centre | 215 | 2020-09-15 | 2022-06-10 |
| Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation Vitamins, Telmisartan, Ciclesonide - Corona Virus Infection, Sars-CoV2 | Phase 2 / Phase 3 | Completed | University Hospital, Bordeaux | 412 | 2020-07-29 | 2026-05-12 |
| Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) Ciclesonide Inhalation Aerosol - Covid-19, Pneumonia, Viral | Phase 2 | Unknown | Ola Blennow, MD, PhD | 98 | 2020-05-29 | 2022-02-02 |
| A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 Ciclesonide Metered Dose Inhaler [Alvesco] - COVID-19 | Phase 2 | Completed | Korea University Guro Hospital | 68 | 2020-04-01 | 2021-06-24 |
| Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma cyklezonid, montelukast sodium, placebo - Asthma | Phase 2 | Unknown | Medical University of Lodz | 200 | 2009-08-01 | 2013-12-10 |
| Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506) Ciclesonide/Formoterol Combination - Asthma | Phase 2 | Completed | AstraZeneca | 240 | 2005-07-01 | 2016-12-05 |
COVID-19 (4) · Asthma (2) · Coronavirus Infections (2) · Glomerulonephritis (1) · Lupus Erythematosus, Systemic (1) · Neoplasms (1) · Pneumonia, Viral (1) · Vasculitis (1)
AstraZeneca (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Korea University Guro Hospital (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Medical University of Lodz (1) · Ola Blennow, MD, PhD (1) · University Hospital, Bordeaux (1)
France (2) · Canada (1) · Germany (1) · Hungary (1) · Poland (1) · South Africa (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
Agnieszka Brzozowska, MD, PhD (1) · Daniel P Andersson, MD, PhD (1) · Iwona Stelmach, MD PhD Prof (1) · Joanna Jerzynska, MD PhD (1) · Ola Blennow, MD, PhD (1) · Rona Smith, Dr (1)
PMID 32738928, PMID 33050924, PMID 33388170, PMID 34441840, PMID 34473343, PMID 34728476, PMID 36813503, PMID 36915199, PMID 38454482, PMID 39934669, PMID 41656183